Progression‐free survival at 2 years post‐autologous transplant: a surrogate end point for overall survival in follicular lymphoma

Overall survival (OS) is the gold‐standard end point for studies evaluating autologous stem cell transplantation (ASCT) in follicular lymphoma (FL), but assessment may be elusive due to the lengthy disease course. We analyzed the validity of two earlier end points, proposed in the setting of first‐l...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiménez‐Ubieto, Ana, Grande, Carlos, Caballero, Dolores, Yáñez, Lucrecia, Novelli, Silvana, Hernández, Miguel T., Manzanares, María, Arranz, Reyes, Ferreiro, José Javier, Bobillo, Sabela, Mercadal, Santiago, Galego, Andrea, Jiménez, Javier López, Moraleda, José María, Vallejo, Carlos, Albo, Carmen, Pérez, Elena, Marrero, Carmen, Magnano, Laura, Palomera, Luis, Jarque, Isidro, Coria, Erika, Rodriguez, Antonia, Martín, Alejandro, López‐Guillermo, Armando, Salar, Antonio, Lahuerta, Juan José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727300/
https://www.ncbi.nlm.nih.gov/pubmed/29076254
http://dx.doi.org/10.1002/cam4.1217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727300/
https://www.ncbi.nlm.nih.gov/pubmed/29076254
http://dx.doi.org/10.1002/cam4.1217

Ejemplares similares